Packaging and dispensing provider Comar recently announced that it is enhancing its offerings through its acquisition of ProPlas Technologies, in yet another example of consolidation in the medical device contract manufacturing space.
“Comar’s recent investments in a class 8 cleanroom and new innovation design center, combined with the acquisition of ProPlas, will position the business to execute on its growth strategy,” Adam Piatkowski, managing principal at Comar’s owner Graham Partners, said in a June 27 news release.
“We continue to actively look for acquisitions of other growth-oriented businesses that can benefit from the resources and infrastructure that Comar has to offer,” Piatkowski added.
Financial terms of the deal were not disclosed.
Comar (Voorhees, N.J.) provides a range of rigid plastic packaging technologies including injection molding, injection blow molding, injection stretch blow molding, and extrusion blow molding – with seven manufacturing and distribution locations. ProPlas (Garden Grove, Calif.) meanwhile specializes in complex injection molding, assembly and mold making.
ProPlas’s 40,000-square-foot facility includes two ISO-class 7 and 8 soft walled cleanrooms, 26 molding machines and five high-speed CNC machines. The company maintains an ISO 13485 certification.
Comar officials said the acquisition will increase offerings for its customers in diagnostics and medical device markets, lower new product development costs and shorten the development cycle.
“They have excellent customer relationships, a very strong employee base and strategic assets and capabilities that will enable us to better serve existing and potential customers,” Comar CEO Mike Ruggieri said of ProPlas.
[Want to stay more on top of MDO content? Subscribe to our weekly e-newsletter.]
